Ethiopia vs Zimbabwe: Cause of death, by non-communicable diseases, female
Ethiopia
43.5%
in 2021
Zimbabwe
44.4%
in 2021
Ethiopia rank
151st
Zimbabwe rank
150th
Cause of death, by non-communicable diseases, female over time
- Ethiopia
- Zimbabwe
How they compare
Zimbabwe currently reports 44.4% against 43.5% in Ethiopia, a difference of 0.9%.
The two have swapped places 1 time across 6 shared years of data; in 2000 it was Ethiopia ahead.
Ethiopia ranks 151st and Zimbabwe ranks 150th of 185 countries.
Across the 3 decades both report, Ethiopia averaged higher in 1 and Zimbabwe in 2.
Head to head by decade
| Decade | Ethiopia | Zimbabwe | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 20.6% | 17.7% | 2.9% | Ethiopia |
| 2010s | 37.5% | 41.2% | 3.8% | Zimbabwe |
| 2020s | 44.2% | 46.3% | 2.2% | Zimbabwe |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cause of death, by non-communicable diseases, female, Ethiopia or Zimbabwe?
- Zimbabwe, at 44.4% against 43.5% in Ethiopia as of 2021.
- What is the difference in cause of death, by non-communicable diseases, female between Ethiopia and Zimbabwe?
- 0.9%, with Zimbabwe ahead.
- How many years of comparable data are there for Ethiopia and Zimbabwe?
- 6 years are reported by both, from 2000 to 2021.
- How do Ethiopia and Zimbabwe rank globally for cause of death, by non-communicable diseases, female?
- Ethiopia ranks 151st and Zimbabwe ranks 150th of 185 countries.
- Where does this data come from?
- Global Health Estimates, World Health Organization (WHO), published as Cause of death, by non-communicable diseases, female (% of total female deaths). Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of female deaths due to non-communicable diseases divided by number of all female deaths, expressed by percentage. Non-Communicable diseases include cancer, diabetes mellitus, cardiovascular diseases, digestive diseases, skin diseases, musculoskeletal diseases, and congenital anomalies.